All In Biotech

Drug Trial Radar · NCT02628665

Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer

Two-arm Phase III Trial Comparing Different Time of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer

Last checked: Nov 19, 2026Latest source record: Dec 11, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

40

Planned (sponsor's estimate)

Start

Oct 2015

Primary completion

Oct 2017

Study completion Dec 2019

Sponsor

Sponsor type
Academic, hospital or other
First posted
Dec 11, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The therapy of photofrin PDT was effective in improving life quality of patients with advanced esophageal and/or gastric cardiac cancer and the time optimizing for employing laser irradiation was of great importance.The purpose of this study is to evaluate the clinical efficacy and adverse effects of Photodynamic Therapy (PDT) on esophageal and/or gastric cardiac cancer during different time after inject photofrin.

Conditions

  • Stage I Esophageal Adenocarcinoma
  • Stage II Esophageal Adenocarcinoma
  • Stage III Esophageal Adenocarcinoma
  • Stage I Esophageal Squamous Cell Carcinoma
  • Stage II Esophageal Squamous Cell Carcinoma
  • Stage III Esophageal Squamous Cell Carcinoma

Interventions

  • photosensitizer(photofrin)Drug

    photosensitizer(photofrin): 2mg/kg

  • 630 nm laser irradiation (DIOMED)Device

    630 nm laser irradiation (DIOMED): The diseased tissue with laser irradiation in 1200 seconds.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Partial remission rateTime frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.